Journal article · 2017 · Open access
Protocol Modification To Determine The Cytotoxic Potential Of Drugs Using Cell Viability Assays That Rely On The Reducing Property Of Viable Cells
Protocol Exchange · Published 20 March 2017 · DOI 10.1038/protex.2017.029
In brief
“Protocol Modification To Determine The Cytotoxic Potential Of Drugs Using Cell Viability Assays That Rely On The Reducing Property Of Viable Cells” is a 2017 journal article by Niraj Konchady Shenoy and 3 co-authors, published in Protocol Exchange. OpenAlex counts 4 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Protocol Exchange.
- Citations
- 4
- Most cited in
- 2017 (1)
- Field-weighted impact
- 1.44
- References
- 4
- Authors
- 4
Abstract
The CellTiter-Blue ® Cell Viability Assay provides a homogeneous, fl uorometric method for estimating the number of viable cells present in multiwell plates.It uses the indicator dye resazurin to measure the metabolic capacity of cells-an indicator of cell viability.Viable cells retain the ability to reduce resazurin into resorufi n, which is highly fl uorescent (Figure 1).Nonviable cells rapidly lose metabolic capacity, do not reduce the indicator dye, and thus do not generate a fl uorescent signal.The CellTiter-Blue ® Reagent is a buff ered solution containing highly purifi ed resazurin.The ingredients have been optimized for use as a cell viability assay.The spectral properties of CellTiter-Blue ® Reagent change upon reduction of resazurin to resorufi n (Figure 2).Resazurin is dark blue in color and has little intrinsic fl uorescence until it is reduced to resorufi n, which is pink and highly fl uorescent (579 Ex /584 Em ).
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Shenoy, N. K., Shenoy, N. K., Wu, X., & Witzig, T. E. (2017). Protocol Modification To Determine The Cytotoxic Potential Of Drugs Using Cell Viability Assays That Rely On The Reducing Property Of Viable Cells. Protocol Exchange. https://doi.org/10.1038/protex.2017.029
MLA 9
Shenoy, Niraj Konchady, et al. “Protocol Modification To Determine The Cytotoxic Potential Of Drugs Using Cell Viability Assays That Rely On The Reducing Property Of Viable Cells.” Protocol Exchange, 2017. https://doi.org/10.1038/protex.2017.029.
Chicago
Shenoy, Niraj Konchady, Niraj Konchady Shenoy, Xiaosheng Wu, and Thomas Elmer Witzig. 2017. “Protocol Modification To Determine The Cytotoxic Potential Of Drugs Using Cell Viability Assays That Rely On The Reducing Property Of Viable Cells.” Protocol Exchange. https://doi.org/10.1038/protex.2017.029.
Harvard
Shenoy, N. K. et al. (2017) ‘Protocol Modification To Determine The Cytotoxic Potential Of Drugs Using Cell Viability Assays That Rely On The Reducing Property Of Viable Cells’, Protocol Exchange. doi:10.1038/protex.2017.029.
IEEE
N. K. Shenoy, N. K. Shenoy, X. Wu, and T. E. Witzig, “Protocol Modification To Determine The Cytotoxic Potential Of Drugs Using Cell Viability Assays That Rely On The Reducing Property Of Viable Cells,” Protocol Exchange, 2017, doi: 10.1038/protex.2017.029.
BibTeX
@article{shenoy2017protocol,
title = {{Protocol Modification To Determine The Cytotoxic Potential Of Drugs Using Cell Viability Assays That Rely On The Reducing Property Of Viable Cells}},
author = {Shenoy, Niraj Konchady and Shenoy, Niraj Konchady and Wu, Xiaosheng and Witzig, Thomas Elmer},
journal = {Protocol Exchange},
year = {2017},
doi = {10.1038/protex.2017.029},
url = {https://doi.org/10.1038/protex.2017.029}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 1 | |
| 2019 | 1 | |
| 2020 | 1 | |
| 2021 | 1 |
Its field-weighted citation impact is 1.44: it has been cited 1.44 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- resazurin
- resorufin
- cell viability assay
- cytotoxicity
- drug cytotoxicity
- cell metabolic activity
Work with this paper
Most-cited papers in Veterinary
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysTim R. Mosmann · Journal of Immunological Methods · 1983 · 57,115 citations
- Guide for the Care and Use of Laboratory Animals: Eighth EditionNational Research Council · National Academies Press eBooks · 2011 · 16,572 citations
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningPhilip Skehan, Ritsa Storeng, Dominic A. Scudiero and 7 more · JNCI Journal of the National Cancer Institute · 1990 · 9,860 citations
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchCarol Kilkenny, William J. Browne, Innes C. Cuthill and 2 more · PLoS Biology · 2010 · 7,617 citations
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal researchNathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia and 25 more · PLoS Biology · 2020 · 6,761 citations
Questions about this paper
How do I cite this paper in APA style?
Shenoy, N. K., Shenoy, N. K., Wu, X., & Witzig, T. E. (2017). Protocol Modification To Determine The Cytotoxic Potential Of Drugs Using Cell Viability Assays That Rely On The Reducing Property Of Viable Cells. Protocol Exchange. https://doi.org/10.1038/protex.2017.029
How many times has this paper been cited?
4 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Protocol Exchange.
Who wrote this paper?
Niraj Konchady Shenoy, Niraj Konchady Shenoy, Xiaosheng Wu, Thomas Elmer Witzig.
What is the DOI of this paper?
10.1038/protex.2017.029. The permanent link is https://doi.org/10.1038/protex.2017.029.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.